Rising rates of early-onset colon cancer (EOCC) present challenges in deciding how to optimally treat patients. Although standard of care for stage II CC is surgical resection, adding chemotherapy for ...

The following represents disclosure information provided by author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Some people have an allergic reaction to chemotherapy. Allergic reactions can range from mild skin irritation to life threatening anaphylaxis. To avoid this, your care team will monitor you during and ...

Chemotherapy is the primary treatment for non-Hodgkin lymphoma, though people may also receive it with immunotherapy. Chemotherapy remains the first-line treatment for non-Hodgkin lymphoma (NHL), a ...

Despite the many advances in cancer care, some adverse events (AEs) remain stubbornly common. Among the most frequent are myelosuppressive events, which occur when chemotherapy damages bone marrow ...

"Therapy for small, node-negative, HER2-positive breast cancer can be challenging due to the risk of overtreatment. Our study can help assess outcomes of patients according to specific tumor sizes and ...

Chemotherapy-induced thrombocytopenia (CIT) is a common complication of chemotherapy that is associated with bleeding, reduced relative dose intensity, and potentially worse outcomes. No widely ...

When chemotherapy drugs accidentally leak into the tissues surrounding your veins or catheter, it’s called extravasation. While it doesn’t happen very often, it’s a serious complication. Chemotherapy ...